Navigation Links
MIT is pleased to announce that it has received a US$ 200,000 private placement from its future Chinese partners
Date:4/28/2009

DENVER, CO, April 28 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca), MIT is pleased to announce that it has received a US$ 200,000 private placement from its future Chinese partners. This private investment from our partners is an important step towards the final stage of the negotiations and a commitment towards MIT's technology and products.

This joint venture agreement will help Medical International Technologies (MIT Canada) Inc. become a world leader in the Needle-Free technology and reduce the world's dependence on needles. Moreover, it will ensure that MIT injectors become an indispensable, environmentally friendly product for single and mass vaccination, and biologics injectables for doctors and users around the world. MIT's mission is to help make the world needle-free.

This technology is the outcome of more than twenty-eight years of research and development and the driving force behind the Med-Jet(R) product line for humans and the Agro-Jet(R) product line for animals.

Medical International Technology Inc. is pleased to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.

Karim Menassa, President

On Behalf of the Board of Directors

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.


'/>"/>
SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AARP Pennsylvania Pleased by House Committee Action
2. AMD Global Telemedicine, Inc is Pleased to Announce the Selection of its Examination Camera for the Canadian National Telehealth Videoconference Equipment RFP
3. RADinfo SYSTEMS(TM) is Pleased to Introduce Their Newly Established Division, VETinfo SYSTEMS(TM)
4. Georgia and South Carolina Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
5. Arkansas and Missouri Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
6. Texas Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
7. ScentToSleep.com Is Pleased to Announce That the Company Was Featured in the September 15th Issue of Womans World Magazine
8. Patients Pleased With Laparoscopic GERD Surgery
9. Heska Announces Q109 Results
10. Genomic Health to Announce First Quarter 2009 Financial Results and Host Conference Call on Tuesday, May 5, 2009
11. Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Kenall Manufacturing, a leader ... MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that meets the ... light where and when it’s needed. , A 2’ x 4’ model ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... and deep lines by smoothing and tightening the skin of the face to ... to address facial aging with very little downtime, Silhouette Instalift is a novel, ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... up with a schizophrenic mother in a unique, personal perspective through animation. ... treating trauma and addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, ...
(Date:12/7/2016)... ... December 07, 2016 , ... In the early morning of October 30, ... medical call when he lost control of his patrol car. The vehicle overturned into ... he was transported to Atlanta Medical Center, where he later succumbed to his injuries. ...
(Date:12/7/2016)... ... December 07, 2016 , ... Castle Dermatology Institute is now offering liquid ... a more youthful appearance to the face. Dr. Peyman Ghasri and Dr. Pedram Ghasri, ... of other treatments, to rejuvenate and renew the facial appearance. , Sculptra is ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... According to a new market research report "Wearable Medical Devices Market by ... (Sports, Fitness, RPM), Type (Smart watch, Patch), Distribution Channel (Pharmacy, Hypermarket) - ... value, is projected to reach 12.14 Billion by 2021 from USD 5.31 ... Continue Reading ... ...
(Date:12/8/2016)... 8, 2016  Hanson Research, an innovative leader ... and diffusion testing instruments for the pharmaceutical industry, ... Instruments, Inc. ("Teledyne"). The move is designed to ... testing instruments, as well as expand resources for ... products and services. Logo - http://photos.prnewswire.com/prnh/20161208/446988LOGO ...
(Date:12/8/2016)... , Dec. 8, 2016 Augmedix, ... announced that it has closed a $23 million ... Ventures and OrbiMed. The company seeks to rehumanize ... physicians spend on mandated EHR documentation. The Augmedix ... service that frees doctors from 3 hours of ...
Breaking Medicine Technology: